Report Detail
Global Hemostats Market Insights, Forecast to 2025
- RnM3048798 |
- 01 March, 2019 |
- Global |
- 126 Pages |
- QYResearch |
- Other
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
For industry structure analysis, the Hemostats Industry is concentrate. The top five producers account for about 56.58% of the revenue market. Regionally, USA e is the biggest consumption area of Hemostats, also the leader in the whole Hemostats.
Major manufacturers in the market are Ethicon, Inc., Pfizer, Inc., Baxter International Inc., C. R. Bard and The Medicines Company.
To grab more market, the little companies have to expand the technology, capital investment and brand influence. To meet the challenge of the little companies and keep their leading stage, leading companies need to increase the technology innovation and speed up the product upgrading. In the future, Hemostats market will be a market of fierce competition.
In order to feed the changing technical requirements, Hemostats manufacturers need to pay attention to the technical innovation. In future, Thrombin-Based Hemostats will be the technology trends of Hemostats.
The global Hemostats market is valued at 2160 million US$ in 2018 and will reach 3410 million US$ by the end of 2025, growing at a CAGR of 5.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Hemostats market based on company, product type, end user and key regions.
This report studies the global market size of Hemostats in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Hemostats in these regions.
This research report categorizes the global Hemostats market by top players/brands, region, type and end user. This report also studies the global Hemostats market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Ethicon
Pfizer
Baxter International Inc.
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences Corporation
B Braun Melsungen AG
Gelita Medical GmbH
Equimedical
Vascular Solutions
Marine Polymer Technologies
Z-Medica, LLC
CryoLife
BioCer Entwicklungs-GmbH.
Biom'Up SAS
Market size by Product
Thrombin-Based Hemostats
Oxidized Regenerated Cellulose Based Hemostats
Combination Hemostats
Gelatin Based Hemostats
Collagen Based Hemostats
Market size by End User
Prehospital Treatment
Hospital Treatment
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Hemostats market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Hemostats market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Hemostats companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Hemostats submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Hemostats are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Hemostats market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Hemostats Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Hemostats Market Size Growth Rate by Product
- 1.4.2 Thrombin-Based Hemostats
- 1.4.3 Oxidized Regenerated Cellulose Based Hemostats
- 1.4.4 Combination Hemostats
- 1.4.5 Gelatin Based Hemostats
- 1.4.6 Collagen Based Hemostats
- 1.5 Market by End User
- 1.5.1 Global Hemostats Market Size Growth Rate by End User
- 1.5.2 Prehospital Treatment
- 1.5.3 Hospital Treatment
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Hemostats Market Size
- 2.1.1 Global Hemostats Revenue 2014-2025
- 2.1.2 Global Hemostats Sales 2014-2025
- 2.2 Hemostats Growth Rate by Regions
- 2.2.1 Global Hemostats Sales by Regions
- 2.2.2 Global Hemostats Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Hemostats Sales by Manufacturers
- 3.1.1 Hemostats Sales by Manufacturers
- 3.1.2 Hemostats Sales Market Share by Manufacturers
- 3.1.3 Global Hemostats Market Concentration Ratio (CR5 and HHI)
- 3.2 Hemostats Revenue by Manufacturers
- 3.2.1 Hemostats Revenue by Manufacturers (2014-2019)
- 3.2.2 Hemostats Revenue Share by Manufacturers (2014-2019)
- 3.3 Hemostats Price by Manufacturers
- 3.4 Hemostats Manufacturing Base Distribution, Product Types
- 3.4.1 Hemostats Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Hemostats Product Type
- 3.4.3 Date of International Manufacturers Enter into Hemostats Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Hemostats Sales by Product
- 4.2 Global Hemostats Revenue by Product
- 4.3 Hemostats Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Hemostats Breakdown Data by End User
6 North America
- 6.1 North America Hemostats by Countries
- 6.1.1 North America Hemostats Sales by Countries
- 6.1.2 North America Hemostats Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Hemostats by Product
- 6.3 North America Hemostats by End User
7 Europe
- 7.1 Europe Hemostats by Countries
- 7.1.1 Europe Hemostats Sales by Countries
- 7.1.2 Europe Hemostats Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Hemostats by Product
- 7.3 Europe Hemostats by End User
8 Asia Pacific
- 8.1 Asia Pacific Hemostats by Countries
- 8.1.1 Asia Pacific Hemostats Sales by Countries
- 8.1.2 Asia Pacific Hemostats Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Hemostats by Product
- 8.3 Asia Pacific Hemostats by End User
9 Central & South America
- 9.1 Central & South America Hemostats by Countries
- 9.1.1 Central & South America Hemostats Sales by Countries
- 9.1.2 Central & South America Hemostats Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Hemostats by Product
- 9.3 Central & South America Hemostats by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Hemostats by Countries
- 10.1.1 Middle East and Africa Hemostats Sales by Countries
- 10.1.2 Middle East and Africa Hemostats Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Hemostats by Product
- 10.3 Middle East and Africa Hemostats by End User
11 Company Profiles
- 11.1 Ethicon
- 11.1.1 Ethicon Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Ethicon Hemostats Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Ethicon Hemostats Products Offered
- 11.1.5 Ethicon Recent Development
- 11.2 Pfizer
- 11.2.1 Pfizer Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Pfizer Hemostats Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Pfizer Hemostats Products Offered
- 11.2.5 Pfizer Recent Development
- 11.3 Baxter International Inc.
- 11.3.1 Baxter International Inc. Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Baxter International Inc. Hemostats Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Baxter International Inc. Hemostats Products Offered
- 11.3.5 Baxter International Inc. Recent Development
- 11.4 C. R. Bard
- 11.4.1 C. R. Bard Company Details
- 11.4.2 Company Business Overview
- 11.4.3 C. R. Bard Hemostats Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 C. R. Bard Hemostats Products Offered
- 11.4.5 C. R. Bard Recent Development
- 11.5 The Medicines Company
- 11.5.1 The Medicines Company Company Details
- 11.5.2 Company Business Overview
- 11.5.3 The Medicines Company Hemostats Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 The Medicines Company Hemostats Products Offered
- 11.5.5 The Medicines Company Recent Development
- 11.6 Anika Therapeutics
- 11.6.1 Anika Therapeutics Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Anika Therapeutics Hemostats Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Anika Therapeutics Hemostats Products Offered
- 11.6.5 Anika Therapeutics Recent Development
- 11.7 Advanced Medical Solutions
- 11.7.1 Advanced Medical Solutions Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Advanced Medical Solutions Hemostats Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Advanced Medical Solutions Hemostats Products Offered
- 11.7.5 Advanced Medical Solutions Recent Development
- 11.8 Integra LifeSciences Corporation
- 11.8.1 Integra LifeSciences Corporation Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Integra LifeSciences Corporation Hemostats Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Integra LifeSciences Corporation Hemostats Products Offered
- 11.8.5 Integra LifeSciences Corporation Recent Development
- 11.9 B Braun Melsungen AG
- 11.9.1 B Braun Melsungen AG Company Details
- 11.9.2 Company Business Overview
- 11.9.3 B Braun Melsungen AG Hemostats Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 B Braun Melsungen AG Hemostats Products Offered
- 11.9.5 B Braun Melsungen AG Recent Development
- 11.10 Gelita Medical GmbH
- 11.10.1 Gelita Medical GmbH Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Gelita Medical GmbH Hemostats Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Gelita Medical GmbH Hemostats Products Offered
- 11.10.5 Gelita Medical GmbH Recent Development
- 11.11 Equimedical
- 11.12 Vascular Solutions
- 11.13 Marine Polymer Technologies
- 11.14 Z-Medica, LLC
- 11.15 CryoLife
- 11.16 BioCer Entwicklungs-GmbH.
- 11.17 Biom'Up SAS
12 Future Forecast
- 12.1 Hemostats Market Forecast by Regions
- 12.1.1 Global Hemostats Sales Forecast by Regions 2019-2025
- 12.1.2 Global Hemostats Revenue Forecast by Regions 2019-2025
- 12.2 Hemostats Market Forecast by Product
- 12.2.1 Global Hemostats Sales Forecast by Product 2019-2025
- 12.2.2 Global Hemostats Revenue Forecast by Product 2019-2025
- 12.3 Hemostats Market Forecast by End User
- 12.4 North America Hemostats Forecast
- 12.5 Europe Hemostats Forecast
- 12.6 Asia Pacific Hemostats Forecast
- 12.7 Central & South America Hemostats Forecast
- 12.8 Middle East and Africa Hemostats Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Hemostats Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Hemostats . Industry analysis & Market Report on Hemostats is a syndicated market report, published as Global Hemostats Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Hemostats market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
